Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARACHILD: Epicutaneous Immunotherapy in Children Allergic to Peanut
NCT01197053Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2010
- Primary completion
- Feb 2015
- Modality
- Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of DBV712 Viaskin® in peanut allergy, sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2010; status: completed.
02
Drugs
DBV712 Viaskin®
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01197053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197053.